| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 01/06/2010 | EP1805278B1 Photochromic h-annellated benzo(f)chrome-derivatives |
| 01/06/2010 | CN101619067A Large ring lactone compound and preparation method thereof |
| 01/06/2010 | CN100577664C Spirocyclic cyclohexane derivatives |
| 01/05/2010 | US7642362 Compounds as semaphorin inhibitors |
| 01/05/2010 | US7642359 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 01/05/2010 | US7642296 Photoinitiators |
| 01/05/2010 | US7642284 Luminacin analogs and uses thereof |
| 01/05/2010 | US7642272 Cannabinoid receptor ligands |
| 12/31/2009 | US20090326248 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases, such as cancer, psoriasis, atherosclerosis and acromegaly; preferred compound is picropodophyllin |
| 12/31/2009 | US20090326239 Fermentative preparation process for and crystal forms of cytostatics |
| 12/30/2009 | WO2009158381A1 Novel psymberin derivatives, compositions, and their use as antineoplastic agents |
| 12/30/2009 | WO2009156966A1 Benzothiazoles and aza-analogues thereof use as antibacterial agents |
| 12/30/2009 | WO2009156092A2 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 12/30/2009 | EP2137177A2 Aurora kinase modulators and method of use |
| 12/30/2009 | EP1448567B1 Method for the preparation of hexahydro-furo 2,3-b furan-3-ol |
| 12/30/2009 | CN101613355A Method for synthesizing pyrano-coumarin derivative |
| 12/30/2009 | CN101613354A Method for preparing pyrano-coumarin derivative |
| 12/30/2009 | CA2728123A1 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 12/29/2009 | US7638640 total pomegranate tannins (TPT) including punicalagin; nutraceutical for cardiovascular health |
| 12/29/2009 | US7638500 Brevenal derivatives; used to treat diseases characterized by decreased mucus clearance or mucociliary dysfunction such as cystic fibrosis; COPD and asthma; and to treat brevetoxin and ciguatoxin poisoning |
| 12/29/2009 | CA2418829C Process for the preparation of baccatin iii derivatives |
| 12/29/2009 | CA2287214C Substituted benzopyran derivatives for the treatment of inflammation |
| 12/24/2009 | US20090318548 Para-quinol derivatives and methods of stereo selectively synthesizing and using same |
| 12/24/2009 | US20090318373 Receptor-type kinase modulators and methods of use |
| 12/24/2009 | US20090317914 Fluorescent probe |
| 12/23/2009 | WO2009155413A1 Thienyl- and furanyl-isoquinolinones and methods for using them |
| 12/23/2009 | WO2009155379A2 Artemisinin and derivatives thereof as antivirals |
| 12/23/2009 | WO2009155020A2 Production of 5-membered and 6-membered cyclic esters of polyols |
| 12/23/2009 | WO2009153168A1 Polymerizable chiral compounds containing 2,6-naphthyl- and isomannite units, and use thereof as chiral dopants |
| 12/23/2009 | EP2135671A2 Catalyst and method for producing carboxylic acid and/or carboxylic anhydride in the presence of the catalyst |
| 12/23/2009 | EP2135606A1 Anti-fatigue agent |
| 12/23/2009 | EP2134336A1 Benzofuran-derived hiv protease inhibitors |
| 12/23/2009 | EP1709037B1 Hiv protease inhibiting sulfonamides |
| 12/23/2009 | EP1483251B1 C3-cyano epothilone derivatives |
| 12/23/2009 | CN101611038A 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents |
| 12/23/2009 | CN101607978A Two novel compounds in gamboge, preparation method and pharmaceutical use |
| 12/23/2009 | CN101607964A Preparation method of cycle epimedium aglucone |
| 12/23/2009 | CN101606929A Application of deoxypodophyllotoxin |
| 12/23/2009 | CA2728466A1 Thienyl- and furanyl-isoquinolinones and methods for using them |
| 12/22/2009 | US7635782 Stereospecific method for the preparation of dioxa-bicyclooctane compounds |
| 12/22/2009 | US7635781 Cyclopentadifuran derivatives; for preparation of catalyst components in the polymerization of olefins, particularly in the production of homo and copolymers of ethylene |
| 12/22/2009 | CA2464336C A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate |
| 12/22/2009 | CA2430090C Improved synthesis of anhydroglycitol esters of improved colour |
| 12/22/2009 | CA2262435C Preparation of sterically hindered amine ethers |
| 12/17/2009 | WO2009150095A1 Pesticidal compositions containing a pyrandione or a thiopyrandione or a cyclohexanetrione derivative |
| 12/17/2009 | WO2009150094A1 Novel herbicides |
| 12/17/2009 | WO2009150093A1 Novel herbicides |
| 12/17/2009 | WO2009150007A1 Angiotensin ii receptor antagonists |
| 12/17/2009 | WO2009091374A3 Fused heterocyclic derivatives and methods of use as c-met inhibitors |
| 12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
| 12/17/2009 | US20090312318 Therapeutic compounds and methods |
| 12/17/2009 | US20090312317 Coumarin compounds and their use for treating cancer |
| 12/17/2009 | CA2724919A1 Angiotensin ii receptor antagonists |
| 12/16/2009 | EP2133343A1 Process for production of optically active epoxy compound |
| 12/16/2009 | CN101605796A Substantially pure fluorescein |
| 12/16/2009 | CN101602770A Method for preparing herbicide |
| 12/16/2009 | CN101602769A Podophyllum triazole derivants and application in preparing antiviral medicament and antitumor medicament |
| 12/16/2009 | CN101602768A Method for purifying sesamin and sesamolin |
| 12/16/2009 | CN101601666A Radix wikstroemae extractive and preparation method and application thereof |
| 12/16/2009 | CN100569944C Production of polyketides and other natural products |
| 12/16/2009 | CN100569781C Dimeric flavone compound as well as preparation and application thereof in preparing anti-cancer medicine |
| 12/16/2009 | CN100569780C Fleshy glossy ganoderma lactone A, preparation process and use thereof |
| 12/16/2009 | CN100569779C Process for producing glucurolactone |
| 12/10/2009 | WO2009148062A1 Polycyclic compound and organic electroluminescent device using the same |
| 12/10/2009 | WO2009148016A1 Halogen compound, polycyclic compound and organic electroluminescent element using the polycyclic compound |
| 12/10/2009 | WO2009148015A1 Halogen compound, polycyclic compound, and organic electroluminescence element comprising the polycyclic compound |
| 12/10/2009 | WO2009147237A1 Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics |
| 12/10/2009 | WO2009146555A1 Hiv integrase inhibitors from pyridoxine |
| 12/10/2009 | WO2009111428A3 Methods for synthesizing glycinols, glyceollins i and ii, compositions of selected intermediates, and therapeutic uses thereof |
| 12/10/2009 | WO2009077677A3 Novel polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same |
| 12/10/2009 | WO2009019005A3 Tricyclic bridged cyclopentanedione derivatives as herbicides |
| 12/10/2009 | US20090304832 Treatment of Parasitic Infections in Humans and Animals |
| 12/10/2009 | US20090301552 Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics |
| 12/10/2009 | CA2726742A1 Hiv integrase inhibitors from pyridoxine |
| 12/09/2009 | EP2130826A1 Annulins A, B, C or analogs as indoleamine 2,3-dioxygenase (IDO) inhibitors for treatment of cancer |
| 12/09/2009 | EP2130820A1 Antipruritics |
| 12/09/2009 | EP1940848B1 Antimitotic rhizoxin derivatives of burkholderia rhizoxina, method for producing said derivatives and use thereof |
| 12/09/2009 | CN101597296A Novel method for efficiently extracting and producing artemisinin by ionic liquid |
| 12/09/2009 | CN101597231A NO donor medicine and synthesis method thereof |
| 12/09/2009 | CN100567304C Leucinocaine 10-O-(dimethylaminoethyl)ginkgolide B semihydrate crystal and preparation method thereof |
| 12/09/2009 | CN100567303C Coumarether compound and use of its composition |
| 12/09/2009 | CN100567289C 2-(hetero)aryl substituted tetrahydroquinoline derivatives |
| 12/08/2009 | US7629381 Such as picropodophyllin, for the inhibition of the insulin-like growth factor-1 receptor; cancer, psoriasis, artherosclerosis and acromegaly |
| 12/08/2009 | CA2422354C Pyrazole compounds useful as protein kinase inhibitors |
| 12/08/2009 | CA2369979C 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 12/03/2009 | WO2009145357A1 In 1-position durch einen ring substituierte benzo [1, 4] diazepine zur verwendungs als antidepressiva |
| 12/03/2009 | WO2009145323A1 Method for oxidizing alcohol by using polycyclic compound |
| 12/03/2009 | WO2009122034A3 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof |
| 12/03/2009 | US20090299061 Fluorescence assays with improved sensitivity |
| 12/03/2009 | US20090298931 Novel chromenone potassium channel blockers and uses thereof |
| 12/03/2009 | US20090298925 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 12/03/2009 | US20090298881 Water-Soluble Artemisinin Derivatives, Their Preparation Methods, the Pharmaceutical Compositions and the Use Thereof |
| 12/03/2009 | US20090298870 Podophyllotoxin derivatives |
| 12/02/2009 | EP1523321B1 Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 12/02/2009 | EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents |
| 12/02/2009 | CN101591343A Dioxaanthanthrene compound and semiconductor device |
| 12/02/2009 | CN101591316A Homoisoflavone, dihydrohomoisoflavone and homoisoflavane derivatives and application thereof |
| 12/02/2009 | CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof |
| 12/02/2009 | CN100564344C 2- and 2,5-substituted phenylketo-enols |
| 12/01/2009 | US7626044 Plant extracts comprising highly bioactive triptolide derivatives with low toxicity;(5-R)-5-hydroxytriptonide, (5R)-5-hydroxytriptolide, (5R)-5-hydroxy-14-epitriptolide. Delta 5,6-dehydrotriptonide, Delta 5,6-dehydrotriptolide; antiinflammatory agents; immunosuppressants; drug design |